Drug intelligence / Profile preview

nifurzide

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Nifurzide is a synthetic nitrofuran derivative and intestinal anti-infectious agent, primarily used as an antimicrobial for the treatment of gastrointestinal infections, especially acute diarrheal diseases caused by bacterial pathogens such as Escherichia coli. It exhibits antibacterial activity against a range of enteric bacteria including Campylobacter, Shigella, Aeromonas, Salmonella, and Yersinia enterocolitica. Nifurzide acts locally in the gut due to its poor solubility and minimal absorption from the gastrointestinal tract; it is not substantially metabolized or systemically distributed. Its mechanism involves binding to bacterial cells and inhibiting their growth at low concentrations or exerting bactericidal effects at higher concentrations. Unlike other nitrofurans, it does not induce significant side effects such as vomiting or monoamine oxidase inhibition[1][3][4][7].

Brand names
ErcefurylRicridene
Other names
Nifurzida39978-42-2
02

Targets

Neuraminidase

Beyond the preview

Go deeper on nifurzide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nifurzide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call